Int J Oral Biol.  2020 Dec;45(4):225-231. 10.11620/IJOB.2020.45.4.225.

Role of microglial activation on neuronal excitability in rat substantia gelatinosa

Affiliations
  • 1Department of Dental Hygiene, Gangdong University, Eumseong 27600, Republic of Korea
  • 2Department of Oral Physiology, College of Dentistry, Wonkwang Dental Research Institute, Wonkwang University, Iksan 54538, Republic of Korea

Abstract

Glial cells, including astrocytes and microglia, interact closely with neurons and modulate pain transmission, particularly under pathological conditions. In this study, we examined the excitability of substantia gelatinosa (SG) neurons of the spinal dorsal horn using a patch clamp recording to investigate the roles of microglial activation in the nociceptive processes of rats. We used xanthine/xanthine oxidase (X/XO), a generator of superoxide anion (O2ยท โ€“ ), to induce a pathological pain condition. X/XO treatment induced an inward current and membrane depolarization. The inward current was significantly inhibited by minocycline, a microglial inhibitor, and fluorocitrate, an astrocyte inhibitor. To examine whether toll-like receptor 4 (TLR4) in microglia was involved in the inward current, we used lipopolysaccharide (LPS), a highly specific TLR4 agonist. The LPS induced inward current, which was decreased by pretreatment with Tak-242, a TLR4-specific inhibitor, and phenyl N-t-butylnitrone, a reactive oxygen species scavenger. The X/XO-induced inward current was also inhibited by pretreatment with Tak-242. These results indicate that the X/XO-induced inward current of SG neurons occurs through activation of TLR4 in microglial cells, suggesting that neuroglial cells modulate the nociceptive process through central sensitization.

Keyword

Substantia gelatinosa neuron; Toll-like receptor 4; Microglia; Patch clamp
Full Text Links
  • IJOB
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr